Open Access

Anlotinib‑induced acute myocardial infarction: A case report and literature review

  • Authors:
    • Guihong Liu
    • Tao Chen
    • Zhenyu Ding
  • View Affiliations

  • Published online on: July 24, 2020     https://doi.org/10.3892/etm.2020.9041
  • Pages: 3203-3207
  • Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Anlotinib hydrochloride is a multi‑target tyrosine kinase inhibitor, which has been recently approved for the treatment of advanced non‑small cell lung cancer in China. One of its mechanisms of action is the inhibition of angiogenesis and it is similar to other anti‑angiogenesis drugs, as it has cardiovascular toxicity, which may damage vascular endothelial cells and result in hypertension and hyperlipidemia. All of the aforementioned factors are considered risk factors for coronary heart disease; however, the risk of developing acute myocardial infarction (AMI) has not been assessed by any previous clinical trials and subsequent research. The present case study, to the best of our knowledge, was the first to report on a patient who developed hypertension, hyperlipidemia and angina pectoris, and eventually experienced AMI, following treatment with anlotinib. This indicates that patients receiving anlotinib may require further observation and monitoring during use.
View Figures
View References

Related Articles

Journal Cover

October-2020
Volume 20 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu G, Chen T and Ding Z: Anlotinib‑induced acute myocardial infarction: A case report and literature review. Exp Ther Med 20: 3203-3207, 2020
APA
Liu, G., Chen, T., & Ding, Z. (2020). Anlotinib‑induced acute myocardial infarction: A case report and literature review. Experimental and Therapeutic Medicine, 20, 3203-3207. https://doi.org/10.3892/etm.2020.9041
MLA
Liu, G., Chen, T., Ding, Z."Anlotinib‑induced acute myocardial infarction: A case report and literature review". Experimental and Therapeutic Medicine 20.4 (2020): 3203-3207.
Chicago
Liu, G., Chen, T., Ding, Z."Anlotinib‑induced acute myocardial infarction: A case report and literature review". Experimental and Therapeutic Medicine 20, no. 4 (2020): 3203-3207. https://doi.org/10.3892/etm.2020.9041